Chargement de la fiche…
Chargement de la fiche…
rhumatologie
Praticien hospitalier
Tourcoing (59208)
COVID-19 Clinical Research Studies · Rheumatoid Arthritis Research and Therapies · Spondyloarthritis Studies and Treatments
Tout est calculé à partir des sources publiques (RPPS, PubMed, OpenAlex, OpenStreetMap…) — aucun classement éditorial.
2019–2023
Centre Hospitalier de Tourcoing
2009
Centre Hospitalier de Valenciennes
2003–2007
Hôpital Rangueil
2006
Médecins du Monde
2006
Société Française de Rhumatologie
2003
Centre Hospitalier Universitaire de Toulouse
0
h-index
0
i10
0
citations
Le h-index mesure la productivité scientifique : ce médecin a publié 6 articles cités au moins 6fois par d'autres chercheurs. Plus c'est élevé, plus son travail influence la communauté médicale.
Côté patient
Comprendre votre pathologie, exercices à domicile, applications validées, paramédicaux à proximité — gratuit, sans inscription.
DES Rhumatologie · Rhumatologie (SM) — Diplôme d'Études Spécialisées
DE Docteur en médecine — Capacité / Certificat d'Études Spéciales
0
travaux
0
h-index
0
i10-index
0
citations
2023Joint bone spine
PubMed ↗Comparing COVID-19 disease severity in patients with rheumatic and inflammatory diseases between the first and the subsequent waves
2023Frontiers in medicine
PubMed ↗CovAID: Identification of factors associated with severe COVID-19 in patients with inflammatory rheumatism or autoimmune diseases
2006Clinical rheumatology
PubMed ↗Remitting seronegative symmetrical synovitis pitting oedema after BCG instillation
2006Clinical rheumatology
PubMed ↗Do new therapeutic approaches (autotransplants, thalidomide, dexamethasone) improve the survival of patients with multiple myeloma followed in a rheumatology department?
2006Joint bone spine
PubMed ↗Systemic vasculitis revealing a benign tumor: a paraneoplastic syndrome?
2006Presse medicale (Paris, France : 1983)
PubMed ↗[Atypical crowned dens syndrome]
2022Revue du rhumatisme (Ed. francaise : 1993)
PubMed ↗Effet d’un traitement par hydroxychloroquine prescrit comme traitement de fond de rhumatismes inflammatoires chroniques ou maladies auto-immunes systémiques sur les tests diagnostiques et l’évolution de l’infection à SARS CoV-2 : étude de 871 patients
2021Joint bone spine
PubMed ↗Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseases
2004Clinical and experimental rheumatology
PubMed ↗Safety of leflunomide plus infliximab combination therapy in rheumatoid arthritis
2004Clinical and experimental rheumatology
PubMed ↗Safety of leflunomide plus infliximab combination therapy in rheumatoid arthritis
2021The Lancet. Rheumatology
PubMed ↗COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
2008Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
PubMed ↗Distal renal tubular acidosis and ovalocytosis: a case report
2003Joint bone spine
PubMed ↗Osteomalacia and sacroiliitis
2023Article
Comparing COVID-19 disease severity in patients with rheumatic and inflammatory diseases between the first and the subsequent waves
Joint Bone Spine
2023Article
CovAID: Identification of factors associated with severe COVID-19 in patients with inflammatory rheumatism or autoimmune diseases
Frontiers in Medicine
2021Article
Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseases
Joint Bone Spine
2021Article
Effet d’un traitement par hydroxychloroquine prescrit comme traitement de fond de rhumatismes inflammatoires chroniques ou maladies auto-immunes systémiques sur les tests diagnostiques et l’évolution de l’infection à SARS CoV-2: étude de 871 patients
Revue du Rhumatisme
2021Article
COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
The Lancet Rheumatology
2020Article
Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients
Annals of the Rheumatic Diseases
Rhumatologues à proximité